IL135331A - Crystalline antifungal polymorph form i and pharmaceutical compositions comprising the same - Google Patents

Crystalline antifungal polymorph form i and pharmaceutical compositions comprising the same

Info

Publication number
IL135331A
IL135331A IL13533198A IL13533198A IL135331A IL 135331 A IL135331 A IL 135331A IL 13533198 A IL13533198 A IL 13533198A IL 13533198 A IL13533198 A IL 13533198A IL 135331 A IL135331 A IL 135331A
Authority
IL
Israel
Prior art keywords
same
pharmaceutical compositions
polymorph form
antifungal
crystalline
Prior art date
Application number
IL13533198A
Other languages
English (en)
Other versions
IL135331A0 (en
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of IL135331A0 publication Critical patent/IL135331A0/xx
Publication of IL135331A publication Critical patent/IL135331A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IL13533198A 1997-10-07 1998-10-05 Crystalline antifungal polymorph form i and pharmaceutical compositions comprising the same IL135331A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94618397A 1997-10-07 1997-10-07
PCT/US1998/020476 WO1999018097A1 (fr) 1997-10-07 1998-10-05 Olymorphe antifongique cristallin

Publications (2)

Publication Number Publication Date
IL135331A0 IL135331A0 (en) 2001-05-20
IL135331A true IL135331A (en) 2005-08-31

Family

ID=25484068

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13533198A IL135331A (en) 1997-10-07 1998-10-05 Crystalline antifungal polymorph form i and pharmaceutical compositions comprising the same

Country Status (31)

Country Link
EP (1) EP1021439B1 (fr)
JP (4) JP2001519346A (fr)
KR (1) KR100626109B1 (fr)
CN (1) CN1125067C (fr)
AR (1) AR015947A1 (fr)
AT (1) ATE263163T1 (fr)
AU (1) AU759982B2 (fr)
BR (1) BR9812866A (fr)
CA (1) CA2305803C (fr)
CO (1) CO4970829A1 (fr)
CZ (1) CZ299835B6 (fr)
DE (1) DE69822859T2 (fr)
DK (1) DK1021439T3 (fr)
ES (1) ES2217594T3 (fr)
HK (1) HK1029588A1 (fr)
HU (1) HU225233B1 (fr)
ID (1) ID29290A (fr)
IL (1) IL135331A (fr)
IN (1) IN1998CH02232A (fr)
MX (1) MX225999B (fr)
MY (1) MY130126A (fr)
NO (1) NO318827B1 (fr)
NZ (1) NZ503662A (fr)
PE (1) PE120499A1 (fr)
PH (1) PH11998002606B1 (fr)
PL (1) PL189317B1 (fr)
PT (1) PT1021439E (fr)
SK (1) SK285190B6 (fr)
TW (1) TW589310B (fr)
WO (1) WO1999018097A1 (fr)
ZA (1) ZA989063B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2130540A1 (fr) 2008-06-02 2009-12-09 Sandoz AG Compositions pharmaceutiques contenant une forme cristalline du posaconazole
EP2141159A1 (fr) 2008-07-03 2010-01-06 Sandoz AG Formule cristalline de posaconazole
EP2451805A1 (fr) 2009-07-09 2012-05-16 Sandoz AG Forme cristalline du posaconazole
JP5956980B2 (ja) 2010-05-19 2016-07-27 サンド・アクチエンゲゼルシヤフト キラル化合物の調製の方法
EP2571868B1 (fr) 2010-05-19 2016-05-04 Sandoz AG Purification du posaconazole et d'intermédiaires du posaconazole
BR112012029227B1 (pt) * 2010-05-19 2020-01-07 Sandoz Ag Processo para a preparação de um composto quiral, composto quiral e uso de um composto
CN102892763B (zh) 2010-05-19 2016-03-09 桑多斯股份公司 泊沙康唑及泊沙康唑中间体的纯化
US9493428B2 (en) 2011-06-16 2016-11-15 Sandoz Ag Process for the preparation of a chiral compound
EP2758385B1 (fr) * 2011-09-19 2018-03-28 MSN Laboratories Limited Procédé pour la préparation de médicament antifongique triazole, ses intermédiaires et polymorphes de celui-ci
MX370849B (es) * 2013-07-25 2020-01-08 Sandoz Ag Proceso mejorado para preparar la forma cristalina iv del posaconazol.
ITMI20132115A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
ITMI20132118A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
ITMI20132114A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
ITMI20132117A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
CN104370894A (zh) * 2014-10-21 2015-02-25 江苏恒盛药业有限公司 无定型泊沙康唑的制备工艺
DK3209647T3 (da) 2014-10-21 2020-08-24 Ariad Pharma Inc Krystallinske former af 5-chlor-n4-[-2-(dimethylphosphoryl) phenyl]-n2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl) piperidin-1-yl]pyrimidin-2,4-diamin
CN104387374A (zh) * 2014-10-21 2015-03-04 江苏恒盛药业有限公司 泊沙康唑晶型i的制备工艺
ES2759801T3 (es) 2015-08-08 2020-05-12 Tiefenbacher Alfred E Gmbh & Co Kg Formulación gastro-resistente que contiene posaconazol
EA039213B1 (ru) 2015-12-24 2021-12-17 Такеда Фармасьютикал Компани Лимитед Сокристалл, способ его получения и лекарственное средство, содержащее сокристалл
EP3210599A1 (fr) 2016-02-26 2017-08-30 Alfred E. Tiefenbacher (GmbH & Co. KG) Formulation gastro-résistante contenant du posaconazole et un inhibiteur de précipitation polymère
CN105949278B (zh) * 2016-03-30 2019-12-06 南京曼杰生物科技有限公司 一种取代的四氢呋喃水溶性衍生物及其应用
WO2017032908A1 (fr) 2016-07-08 2017-03-02 Synthon B.V. Composition pharmaceutique comprenant du posaconazole amorphe
TR201620462A2 (tr) 2016-12-31 2018-07-23 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi POSAKONAZOL İÇEREN FARMASÖTİK BİLEŞİMLER ve ÜRETİM YÖNTEMİ
TR201722493A2 (tr) 2017-12-28 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Posakonazol i̇çeren kati farmasöti̇k kompozi̇syon
EP4196096A1 (fr) 2020-08-13 2023-06-21 Alfred E. Tiefenbacher (GmbH & Co. KG) Formulation à haute résistance entérosoluble contenant du posaconazole
EP4091604B1 (fr) 2021-11-25 2024-04-03 Alfred E. Tiefenbacher (GmbH & Co. KG) Granules contenant du posaconazole
EP4181883A1 (fr) 2021-11-25 2023-05-24 Alfred E. Tiefenbacher (GmbH & Co. KG) Granules contenant du posaconazole

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL103558A0 (en) * 1991-10-30 1993-03-15 Schering Corp Tri-substituted tetrahydrofuran antifungals
CA2179396C (fr) * 1993-12-21 2001-04-17 Anil K. Saksena Tetrahydrofuranes antifongiques
KR100352147B1 (ko) * 1994-01-24 2002-11-11 얀센 파마슈티카 엔.브이. 수용성아졸항진균제
US5625064A (en) * 1995-04-19 1997-04-29 Schering Corporation Process for the preparation of triazolones
NZ309281A (en) * 1995-06-02 1998-07-28 Schering Corp (2r-cis)-4-[4-[4-[4-[[(5-(2,4-dihalophenyl)-tetrahydro-5-(1h-1,2,4-tr iazol-1-ylmethyl)-tetrahydrofuran-3-yl]methoxy]phenyl]2,4-dihydro-2-[ esters and ethers of mono- or dihydroxy-substituted (c4-c5) alkyl]-3h-1,2,4-triazol-3-one

Also Published As

Publication number Publication date
NO20001779L (no) 2000-06-06
AR015947A1 (es) 2001-05-30
PH11998002606B1 (en) 2006-08-10
MXPA00003404A (es) 2000-11-01
PL339659A1 (en) 2001-01-02
MX225999B (es) 2005-02-02
HUP0004899A2 (hu) 2002-02-28
JP2012153730A (ja) 2012-08-16
JP2008106075A (ja) 2008-05-08
IL135331A0 (en) 2001-05-20
CA2305803C (fr) 2009-12-22
CA2305803A1 (fr) 1999-04-15
EP1021439B1 (fr) 2004-03-31
EP1021439A1 (fr) 2000-07-26
ID29290A (id) 2001-08-16
CN1125067C (zh) 2003-10-22
KR100626109B1 (ko) 2006-09-20
SK5122000A3 (en) 2000-09-12
HU225233B1 (en) 2006-08-28
PL189317B1 (pl) 2005-07-29
HK1029588A1 (en) 2001-04-06
NO20001779D0 (no) 2000-04-06
JP2012153729A (ja) 2012-08-16
DE69822859T2 (de) 2005-01-27
JP2001519346A (ja) 2001-10-23
CZ299835B6 (cs) 2008-12-10
CN1281449A (zh) 2001-01-24
PT1021439E (pt) 2004-07-30
SK285190B6 (sk) 2006-08-03
AU9780398A (en) 1999-04-27
TW589310B (en) 2004-06-01
PE120499A1 (es) 1999-12-04
BR9812866A (pt) 2000-08-08
KR20010030959A (ko) 2001-04-16
ATE263163T1 (de) 2004-04-15
DK1021439T3 (da) 2004-05-10
AU759982B2 (en) 2003-05-01
IN1998CH02232A (fr) 2005-03-04
CZ20001264A3 (cs) 2000-08-16
DE69822859D1 (de) 2004-05-06
NZ503662A (en) 2002-10-25
ES2217594T3 (es) 2004-11-01
WO1999018097A1 (fr) 1999-04-15
MY130126A (en) 2007-06-29
HUP0004899A3 (en) 2002-03-28
NO318827B1 (no) 2005-05-09
ZA989063B (en) 1999-04-06
CO4970829A1 (es) 2000-11-07

Similar Documents

Publication Publication Date Title
IL135331A (en) Crystalline antifungal polymorph form i and pharmaceutical compositions comprising the same
IL139479A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
IL144879A0 (en) Hererocyclic biphenyl compounds and pharmaceutical compositions containing the same
GB9706089D0 (en) Pharmaceutical composition
GB9727053D0 (en) Pharmaceutical compositions
IL143841A0 (en) Amide compounds and pharmaceutical compositions containing the same
IL136937A0 (en) τ-GLUTAMYL AND β-ASPARTYL CONTAINING COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
CY2569B1 (en) Pharmaceutical compositions
GB9818591D0 (en) Pharmaceutical composition
GB9717444D0 (en) Pharmaceutical composition
IL131995A0 (en) Gastric-retained pharmaceutical compositions
GB9723985D0 (en) Pharmaceutical compositions
GB9717428D0 (en) Pharmaceutical composition
GB9726735D0 (en) Pharmaceutical compositions
HK1044117B (zh) 藥物組合物
HU9700632D0 (en) Pharmaceutical compositions
GB9717770D0 (en) Pharmaceutical composition
GB2321190B (en) Pharmaceutical composition
ZA982117B (en) Pharmaceutical compositions
IL148427A0 (en) Compound f-15078 and pharmaceutical compositions containing the same
GB9726781D0 (en) Pharmaceutical composition
HU9800078D0 (en) Pharmaceutical composition
HUP0004274A3 (en) Bispyrido-cycloheptane compounds and pharmaceutical compositions thereof
GB9714081D0 (en) Pharmaceutical compositions
GB9710527D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired